GCP Good Clinical Practice GMR Goemetric mean ratio glycosylated haemoglobin HCTZ Hydrochlorothiazide HF Heart Failure Heart failure with preserved ejection fraction HFrEF Heart failure with reduced ejection fraction HTN hypertension IC50 Concentration leading to 50% inhibition INR International normalised ratio ITT intent to treat (population) iv Intravenous(ly) IVRS Interactive Response System KCCQ Kansas City Cardiomyopathy Questionnaire LAVI left atrial volume index sacubitrilat Active moiety of AHU377 LCZ696 r the sacubitril/valsartan combination LFT Liver function test LHFQ Living with Heart Failure Questionnaire LLN limit of normal LSM least squares mean LVEDP left ventricular end diastolic pressure LVEDV left ventricular end diastolic volume LVEF left ventricular ejection fraction LVESV left ventricular end systolic volume
GCP Good Clinical Practice GMR Goemetric mean ratio glycosylated haemoglobin HCTZ Hydrochlorothiazide HF Heart Failure Heart failure with preserved ejection fraction HFrEF Heart failure with reduced ejection fraction HTN hypertension IC50 Concentration leading to 50% inhibition INR International normalised ratio ITT intent to treat (population) iv Intravenous(ly) IVRS Interactive Response System KCCQ Kansas City Cardiomyopathy Questionnaire LAVI left atrial volume index sacubitrilat Active moiety of AHU377 LCZ696 r the sacubitril/valsartan combination LFT Liver function test LHFQ Living with Heart Failure Questionnaire LLN limit of normal LSM least squares mean LVEDP left ventricular end diastolic pressure LVEDV left ventricular end diastolic volume LVEF left ventricular ejection fraction LVESV left ventricular end systolic volume
auspar-sacubitril-valsartan-salt-complex-160923-cer.docx